TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive NCI advisors approve recompetition of $62 million phase II contracts program. November 19, 2004
TCL Archive In Brief: Oncology Nurse Rumored For NCAB; Rosenberg To Give Karofsky Lecture; Fundraiser’s $$ Short December 14, 1990
TCL Archive Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions September 27, 1996